2017
DOI: 10.3389/fmicb.2017.00303
|View full text |Cite
|
Sign up to set email alerts
|

MLKL Mediated Necroptosis Accelerates JEV-Induced Neuroinflammation in Mice

Abstract: Japanese encephalitis virus (JEV) is the most prevalent cause of viral encephalitis in Asia and the western Pacific. Neuronal death caused by JEV infection and inflammation induced cytotoxicity leads to progression and deterioration of Japanese encephalitis (JE). Mixed-lineage kinase domain-like protein (MLKL) mediated necroptosis is a newly discovered pathway of programmed cell death and participates in many inflammatory diseases. In this study, we demonstrated for the first time that necroptosis was involved… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(27 citation statements)
references
References 37 publications
2
25
0
Order By: Relevance
“…Unlike apoptosis, pyroptosis is accompanied by the release of IL-1β, IL-18, and other pro-inflammatory cytokines, causing vehement inflammatory responses. Currently, necroptotic death induced by JEV infection has only been reported in neurons [25]. Our results suggest that a number of JEV-infected macrophages underwent necroptosis.…”
Section: Discussionmentioning
confidence: 47%
“…Unlike apoptosis, pyroptosis is accompanied by the release of IL-1β, IL-18, and other pro-inflammatory cytokines, causing vehement inflammatory responses. Currently, necroptotic death induced by JEV infection has only been reported in neurons [25]. Our results suggest that a number of JEV-infected macrophages underwent necroptosis.…”
Section: Discussionmentioning
confidence: 47%
“…Necroptosis participates in nervous-system pathologies with prominent axonal degeneration, such as multiple sclerosis (Ofengeim et al, 2015), ALS Ito et al, 2016), PD (Iannielli et al, 2018), AD (Caccamo et al, 2017), and neuroinflammation (Bian et al, 2017;Daniels et al, 2017), among others Vieira et al, 2014). This research has established that there are both neuronal-autonomous roles for necroptosis and noncell autonomous mechanisms participating in nervous-system dysfunction (Tonnus and Linkermann, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Recent reports associated the activation of necroptosis to several neurodegenerative conditions (reviewed in Yuan et al, 2019). Inhibition of necroptosis with small molecules or genetic ablation of RIPK1, RIPK3 or MLKL exert neuroprotective effects in models of brain damage, including ischemia (Qu et al, 2016;Yin et al, 2015;Zhang et al, 2016b), traumatic injury (You et al, 2008), viral infections (Bian et al, 2017), in addition to contribute to retinal damage (Dong et al, 2012;Kim et al, 2016;Viringipurampeer et al, 2014) and spinal cord injury (Liu et al, 2015). Recent advances in the field have demonstrated the therapeutic potential of inhibiting necroptosis in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) (Ito et al, 2016;Re et al, 2014) multiple sclerosis (MS) (Ofengeim et al, 2015) and Alzheimer's disease (AD) (Caccamo et al, 2017).…”
Section: Introductionmentioning
confidence: 99%